Fuda Cancer Hospital
Fuda Cancer Hospital
Cina, Canton
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.
He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.
His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
Lymphangioma is not cancer. It is a benign malformation of the lymphatic system. In China, clinicians confirm the diagnosis through high-resolution imaging and histopathology. Specialists use specific markers like D2-40 to rule out rare malignancies. This process ensures accurate treatment planning for fluid-filled cysts.
Bookimed Expert Insight: While lymphangioma is benign, its location near vital structures often requires specialized intervention. Facilities like Fuda Cancer Hospital in Guangzhou utilize vascular interventional therapy and minimally invasive cryosurgery. This is particularly valuable when the malformation is located near major blood vessels. Choosing a JCI-accredited facility ensures the pathology lab meets international standards for complex IHC staining.
Patient Consensus: Patients note it is important to seek specialists who regularly distinguish these growths from similar-sounding conditions. They emphasize that clear MRI results help manage the anxiety of waiting for biopsy confirmation.
China offers a multidisciplinary approach for lymphangioma treatment. Specialists use sclerotherapy as a first-line therapy for cystic lesions. Advanced facilities like Fuda Cancer Hospital employ minimally invasive technologies such as NanoKnife and cryosurgery. Surgical excision remains the definitive standard for microcystic cases.
Bookimed Expert Insight: Patient volume at specialized centers like Fuda Cancer Hospital exceeds 30,000 international cases. This high volume allows surgeons to master cryosurgery for lesions others might deem inoperable. Look for clinics with JCI accreditation to ensure safety protocols match global standards.
Patient Consensus: Patients emphasize that sclerotherapy often requiring multiple sessions and significant swelling is normal. They recommend verifying if a lesion is macrocystic or microcystic before choosing between surgery and injections.
Surgery offers lower recurrence rates for localized lymphangiomas but carries higher risks of nerve injury and scarring. Chinese centers report surgical recurrence rates under 10% for well-defined lesions. In contrast, sclerotherapy recurrence can exceed 50% for larger vessels though it involves significantly less procedural pain.
Bookimed Expert Insight: While surgery seems definitive, Fuda Cancer Hospital in Guangzhou specializes in vascular interventional therapies for complex cases. Our data shows JCI-accredited facilities often use interventional techniques when lesions are near vital nerves. This approach prioritizes functional safety over the aggressive removal seen in traditional open surgery.
Patient Consensus: Patients note that surgery feels more final for well-defined lesions but worry about visible scarring. Many highlight that sclerotherapy often requires multiple sessions and causes temporary swelling before the lesion begins to shrink.
China leading hospitals for lymphangioma care include Shanghai Ninth People Hospital and Beijing Children Hospital. These centers specialize in vascular malformations. They use sclerotherapy and micro-resection. Facilities in Beijing, Shanghai, and Guangzhou offer multidisciplinary teams. These teams include pediatric surgeons and interventional radiologists.
Bookimed Expert Insight: While university hospitals in Shanghai and Beijing are famous for volume, Fuda Cancer Hospital in Guangzhou offers a distinct advantage for international patients through its JCI accreditation and experience treating people from over 100 countries. This global focus often translates into smoother logistics and more robust support for non-residents compared to strictly public institutions.
Patient Consensus: Patients emphasize that treating lymphangiomas near the neck or airway requires a team with strong pediatric anesthesiology and ICU backup. Many note that combined approaches using both sclerotherapy and surgery often provide better long-term results than surgery alone.
Recurrence is not inevitable following lymphangioma treatment. Success depends heavily on the lesion architecture and treatment method chosen. Complete surgical excision offers the lowest recurrence rate of 11% to 17%. Conversely, simple aspiration almost always leads to regrowth because the underlying malformed vascular lining remains intact.
Bookimed Expert Insight: While many associate lymphangioma care with pediatric centers, JCI-accredited oncology hospitals like Fuda Cancer Hospital in Guangzhou apply advanced interventional therapies. Their expertise in vascular interventional therapy and cryosurgery is often reserved for complex adult cases. This is significant because specialized interventional approaches can stabilize lesions that were previously considered too infiltrative for standard surgery.
Patient Consensus: Patients note that recurrence isn't automatic, especially when lesions are treated early. Many emphasize that swelling after treatment can sometimes be simple inflammation or infection rather than true regrowth.
Chinese hospitals provide extensive pediatric expertise for international children through specialized private networks and elite public international departments. Facilities in major cities like Beijing and Guangzhou offer Western-trained doctors and JCI-accredited care. Specialized pediatric oncology and vascular anomaly teams treat complex conditions like lymphangioma using advanced techniques.
Bookimed Expert Insight: While many search for oncology generally, our data shows that specialized centers like Fuda Cancer Hospital in Guangzhou serve patients from over 100 countries. This high international volume is a key quality signal for rare pediatric conditions. Expert surgeons like Prof. Liu Shi Xin at Xiamen Humanity Hospital hold dual expertise in pediatric oncology and precision radiotherapy. This cross-specialty knowledge is vital for complex lymphangiomas that may require multidisciplinary management beyond simple surgery.
Patient Consensus: Parents emphasize that finding a team with specific pediatric vascular anomaly experience is more important than general surgical availability. They note it is critical to confirm the hospital has pediatric airway backup for lesions located in the neck or oral cavity.